William Blair Starts LogicBio Therapeutics (LOGC) at Outperform
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $2.07 --0%
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 51
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 51
Join SI Premium – FREE
William Blair analyst Raju Prasad initiates coverage on LogicBio Therapeutics (NASDAQ: LOGC) with a Outperform rating.
For an analyst ratings summary and ratings history on LogicBio Therapeutics click here. For more ratings news on LogicBio Therapeutics click here.
Shares of LogicBio Therapeutics closed at $13.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts On Holding AG (ONON) at Outperform, 'e see a path to three-year revenue growth above 25%'
- BRF - Brasil Foods S.A. (BRFS3:BZ) (BRFS) PT Raised to BRL19 at Itau BBA
- Evercore ISI Starts Analog Devices (ADI) at Outperform, 'MXIM + LLTC Synergies Imminent'
Create E-mail Alert Related Categories
New CoverageRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
